InMode Ltd vs Lionsgate Studios Corp Common Shares — how do they compare? InMode Ltd trades at $14.29 (market cap $823.46M), while Lionsgate Studios Corp Common Shares trades at $10.86 (market cap $3.31B). The key difference: Lionsgate Studios Corp Common Shares is far larger — about 4× InMode Ltd's market cap, and InMode Ltd is more actively traded (427,627 versus 2,146,134). Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 28 Days and Lionsgate Studios Corp Common Shares for 0 Days on average.
| INMD | LION | |
|---|---|---|
Market Cap | $823.46M | $3.31B |
Volume | 427,627 | 2,146,134 |
Sector | Health | Technology |
52-Week High | $16.62 | $16.40 |
52-Week Low | $12.76 | $5.91 |
Typical Hold Time | 28 Days | 0 Days |
Enterprise Value | $326.79M | $6.82B |
Signals from Pluang's Aura AI — not financial advice
InMode (INMD) trades at $14.305, showing minimal daily movement with a 0.03% gain. The stock maintains a bullish technical signal despite mixed indicators, with RSI suggesting mild overbought conditions. Fundamentally, the company demonstrates strong profitability with 76.52% gross margins and 20.69% net income margins, though 2026 guidance shows potential margin compression. Recent developments include the launch of Morpheus8 Cool technology and an unsolicited acquisition offer from Steel Partners at $16.75 per share in July 2026.
The investment outlook balances attractive valuation metrics (P/E of 11.83, EV/EBITDA of 4.68) against cyclical industry headwinds and management capital allocation concerns. Analyst sentiment is divided with 45% buy ratings, while technicals suggest near-term consolidation around current levels. Key risks include US platform sales decline and execution on international growth strategy.
LION trades at $11.12, up 0.36% on the day, with a market cap of approximately $1.3 billion. The stock shows mixed signals: strong analyst support (87.5% buy rating) and a consensus price target of $16.80 suggest upside, but negative net income and shareholder equity highlight financial strain. Recent Q1 2027 earnings beat estimates with EPS of $0.37, yet the company remains unprofitable with a net loss of $128.5 million in 2025. Takeover interest from firms like Bolloré adds speculative appeal.
The outlook hinges on operational turnaround and potential M&A. Revenue growth from hit films like 'Michael' and a valuable content library offer catalysts, but high debt ($3.65B total) and consistent losses pose significant risks. Investors should weigh the 51% upside to price targets against fundamental weaknesses and industry volatility.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →Lionsgate Studios Corp. is a standalone content company that develops, finances, produces, and distributes motion pictures and television series, licensing its content to theaters, streaming platforms, television networks, and home entertainment channels.
Read more on LION →